ロード中...
Dzherelo (Immunoxel) as adjunctive therapy to standard antituberculosis treatment in patients with pulmonary tuberculosis: a systematic review and meta-analysis of clinical trials
BACKGROUND: Dzherelo (Immunoxel) is one of the few approved immunomodulators that has been shown to produce positive treatment outcomes in patients with tuberculosis (TB). The aim of this review was to assess the effectiveness of Immunoxel used as adjunct therapy with conventional anti-TB therapy fo...
保存先:
| 出版年: | Syst Rev |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8157410/ https://ncbi.nlm.nih.gov/pubmed/34039420 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13643-021-01698-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|